AllianceBernstein’s Takeda Pharmaceutical TAK Stock Holding History

AllianceBernstein’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$232K	Buy	12,522 +1,780	+17%	+$29.5K	﹤0.01%	3101
2026 Q1	$167K	Buy	+10,742	New	+$189K	﹤0.01%	3091
2022 Q2	–	Sell	-251,187	Closed	-$3.6M	–	3373
2022 Q1	$3.6M	Buy	251,187 +48,877	+24%	+$718K	﹤0.01%	1745
2021 Q4	$2.76M	Buy	+202,310	New	+$2.84M	﹤0.01%	1953
2019 Q3	–	Sell	-548,154	Closed	-$9.7M	–	3179
2019 Q2	$9.7M	Sell	548,154 -401,865	-42%	-$7.31M	0.01%	1076
2019 Q1	$19.4M	Buy	+950,019	New	+$19.1M	0.01%	806

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

AllianceBernstein's TAK Position: Q2 2026 in Review

AllianceBernstein increased its Takeda Pharmaceutical (TAK) stake by 17% in Q2 2026, buying an estimated $29.5K and bringing the position to 12,522 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #3101.

AllianceBernstein first reported a position in TAK in Q1 2019 and has held it in 6 quarters since. The position peaked at $19.4M in Q1 2019. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

AllianceBernstein held 12,522 shares of Takeda Pharmaceutical worth $232K as of Q2 2026.
AllianceBernstein bought 1,780 Takeda Pharmaceutical shares in Q2 2026, an estimated $29.5K.
Takeda Pharmaceutical made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #3101 holding.
AllianceBernstein first reported a position in Takeda Pharmaceutical in Q1 2019 and has held it in 6 quarters since.
AllianceBernstein's Takeda Pharmaceutical position peaked at $19.4M in Q1 2019.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.